Track STRATA Skin Sciences's long-term debt ($1.4M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for SSKN is $1.4M as of December 2025. That compares with $920K in the prior-year period — up 49.7% year over year. Investors often review this figure alongside STRATA Skin Sciences's historical trend and sector peers before judging valuation or financial health.
Over the past year, SSKN's long-term debt moved from $920K to $1.4M — a 49.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in STRATA Skin Sciences's operating scale or balance-sheet position.
A long-term debt figure of $1.4M for SSKN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting SSKN's long-term debt ($1.4M), review year-over-year change from $920K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack STRATA Skin Sciences's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.